BRÈVE

sur IFabric Corp (isin : CA45172X2032)

IFabric Corp Achieves FDA Medical Device Registration for Innovative Apparel

On April 30, 2024, iFabric Corp, a leader in textile and apparel innovations, announced that its subsidiary, Intelligent Fabric Technologies (North America) Inc. (IFTNA), has successfully obtained a U.S. Food and Drug Administration Medical Device Registration. This registration is for its apparel products that integrate multiple textile technologies.

Giancarlo Beevis, President and Chief Executive Officer of IFTNA, expressed this milestone as a significant advancement in combining textile technology with healthcare benefits. The FDA registration confirms the effectiveness and safety of their apparel products, marking IFTNA as a credible entity in healthcare solutions. This achievement not only enhances IFTNA's reputation but also facilitates future exploration of additional medical device registrations and expansion in the healthcare sector.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de IFabric Corp